Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk

hat tip Yaya Link to AHA Journal (American Heart Association) Abstract Warning Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is … Continue reading Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk